FINWIRES · TerminalLIVE
FINWIRES

$TLX

6 stories mentioning TLX

Every FINWIRES story that references TLX, newest first.

Sectors

Sector Update: Healthcare Stocks Down Premarket Tuesday

Healthcare stocks were lower premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.1% and the iShares Biotechnology ETF (IBB) easing 0.3%.Hims & Hers Health (HIMS) stock was up more than 2% after the company said it has completed its acquisition of Eucalyptus, expanding its consumer health platform across Australia, Canada, Germany, and other international markets.Heron Therapeutics (HRTX) shares were down 18% after the company said the US District Court for the District of Delaware has ruled that claims in two of its Cinvanti injectable emulsion patents are invalid.Telix Pharmaceuticals (TLX) and United Imaging Healthcare North America signed a memorandum of understanding for a research collaboration in the US focused on integrated theranostics solutions. Telix Pharmaceuticals stock was down more than 2% pre-bell.

$HIMS$HRTX$IBB$TLX$XLV
Insider Trading

Telix Pharmaceuticals Insider Bought Shares Worth $996,738, According to a Recent SEC Filing

Christian Behrenbruch, Managing Director and Group Chief Executive Officer, on April 28, 2026, executed a purchase for 67,935 shares in Telix Pharmaceuticals (TLX) for $996,738. Following the Form 4 filing with the SEC, Behrenbruch has control over a total of 20,742,935 ordinary shares of the company, with 20,742,935 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2007191/000162828026031608/xslF345X05/wk-form4_1778117523.xml

$TLX
Sectors

Sector Update: Health Care Stocks Mixed Pre-Bell Monday

Health care stocks were mixed pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.5% lower and the iShares Biotechnology ETF (IBB) up 0.4%Spyre Therapeutics (SYRE) shares were up more than 29% after the company said its SPY001 investigational treatment for moderate-to-severely active ulcerative colitis met its primary and key secondary endpoints in a phase 2 trial.IDEAYA Biosciences (IDYA) stock was up more than 5% after the company said its phase 2/3 registrational trial evaluating darovasertib in combination with crizotinib in patients with metastatic uveal melanoma met its primary endpoint.Regeneron Pharmaceuticals (REGN) and Telix Pharmaceuticals (TLX) said they will jointly develop and commercialize next-generation radiopharmaceutical therapies. Telix Pharmaceuticals shares were up more than 5% premarket.

$IBB$IDYA$REGN$SYRE$TLX$XLV
Sectors

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

Health care stocks were mixed pre-bell Friday, with the iShares Biotechnology ETF (IBB) 0.5% higher and the State Street Health Care Select Sector SPDR ETF (XLV) marginally lower.Telix Pharmaceuticals (TLX) shares were up more than 5% after the company said the US Food and Drug Administration accepted its resubmitted new drug application for its investigational glioma imaging agent Pixclara.Abbott Laboratories (ABT) has been ordered by a jury in Chicago to pay $53 million in compensatory damages to a group of families related to four cases over its infant formula, the Chicago Tribune reported. Shares of Abbott Laboratories were down 0.9% premarket.Vanda Pharmaceuticals (VNDA) said it is calling on the US Food and Drug Administration to withdraw a proposal in the regulator's fiscal 2027 Congressional Budget Justification that would extend drug review timelines. Vanda Pharmaceuticals stock was up more than 1% pre-bell.

$ABT$IBB$TLX$VNDA$XLV
Asia Markets

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Amid Lingering Geopolitical Uncertainty, CPI Focus

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.1% and the actively traded Invesco QQQ Trust (QQQ) was 0.1% higher in Friday's premarket activity amid lingering geopolitical uncertainty and the release of consumer inflation data.US stock futures were mixed, with S&P 500 Index futures up 0.03%, Dow Jones Industrial Average futures slipping 0.04%, and Nasdaq futures gaining 0.1% before the start of regular trading.US consumer prices rose 0.9% in March, in line with expectations, compared with a 0.3% gain in the prior month.The University of Michigan's preliminary consumer sentiment index for April and the factory orders data for February are due to be released at 10 am ET.In premarket activity, bitcoin was up by 0.1%. Among cryptocurrency ETFs, the cryptocurrency fund ProShares Bitcoin Strategy ETF (BITO) was 0.3% higher, Ether ETF (EETH) advanced 0.2%, and Bitcoin & Ether Market Cap Weight ETF (BETH) gained 0.3%.Power Play:Health CareThe State Street Health Care Select Sector SPDR ETF (XLV) retreated marginally by 0.01%, the Vanguard Health Care Index Fund (VHT) was up 0.8%, while the iShares US Healthcare ETF (IYH) was inactive. The iShares Biotechnology ETF (IBB) slipped 0.4%.Telix Pharmaceuticals (TLX) stock was up more than 9% premarket after the company said the US Food and Drug Administration accepted its resubmitted new drug application for its investigational glioma imaging agent Pixclara.Winners and Losers:ConsumerThe State Street Consumer Staples Select Sector SPDR ETF (XLP) was flat and the Vanguard Consumer Staples Index Fund ETF Shares (VDC) was up 0.8%. The iShares US Consumer Staples ETF (IYK) advanced 0.4%. The State Street Consumer Discretionary Select Sector SPDR ETF (XLY) gained 0.1%. The VanEck Retail ETF (RTH) was inactive, while the State Street SPDR S&P Retail ETF (XRT) was down 0.4%.Shake Shack (SHAK) shares were up more than 3% pre-bell after Mizuho upgraded the company's stock to outperform from neutral and lifted its price target to $120 from $100.FinancialThe State Street Financial Select Sector SPDR ETF (XLF) retreated 0.2%. Direxion Daily Financial Bull 3X Shares (FAS) was down 0.6%, while its bearish counterpart Direxion Daily Financial Bear 3X Shares (FAZ) was 0.8% higher.SLM (SLM) shares were up more than 2% pre-bell. RBC cut the company's price target to $28 from $32 while maintaining its outperform rating.TechnologyThe State Street Technology Select Sector SPDR ETF (XLK) gained 0.2%, and the iShares US Technology ETF (IYW) was 0.2% higher, while the iShares Expanded Tech Sector ETF (IGM) was up 0.01%. Among semiconductor ETFs, the State Street SPDR S&P Semiconductor ETF (XSD) was 0.7% higher, while the iShares Semiconductor ETF (SOXX) rose by 0.7%.Taiwan Semiconductor Manufacturing (TSM) shares were up more than 2% in premarket activity after the company reported higher Q1 net revenue.IndustrialThe State Street Industrial Select Sector SPDR ETF (XLI) advanced 0.3%, while the Vanguard Industrials Index Fund (VIS) gained 0.3% and the iShares US Industrials ETF (IYJ) was inactive.A. O. Smith Corporation (AOS) stock was up more than 1% before the opening bell after Goldman Sachs raised its price target to $61 from $69.EnergyThe iShares US Energy ETF (IYE) was flat, while the State Street Energy Select Sector SPDR ETF (XLE) was down by 0.2%.Eni (E) stock was up nearly 1% before Friday's opening bell after the company said it has invested $70 million in Nouveau Monde Graphite (NMG). Nouveau stock was down 9%.CommoditiesFront-month US West Texas Intermediate crude oil gained 0.1% to reach $97.95 per barrel on the New York Mercantile Exchange. Natural gas retreated by 1.5% to $2.63 per 1 million British Thermal Units. The United States Oil Fund (USO) was down by 1.8%, while the United States Natural Gas Fund (UNG) was 1.2% lower.Gold futures for May were down by 0.6% at $4,790.50 an ounce on the Comex. Silver futures declined by 0.9% to $75.76 an ounce. SPDR Gold Shares (GLD) was 0.01% higher, and the iShares Silver Trust (SLV) advanced by 0.3%.

Dow JonesNasdaq CompositeS&P 500$AOS$BETH$BITO$E$EEM$EETH$EXI$FAS$FAZ$GLD$IBB$IGM$IGV$IPK$IVV$IWM$IYE$IYH$IYJ$IYK$IYW$NMG$PMR$QQQ$RTH$SHAK$SLM$SLV$SOXX$SPY$TLX$TSM$UNG$USO$VDC$VHT$VIS$XLE$XLF$XLI$XLK$XLP$XLV$XLY$XRT$XSD
Sectors

Sector Update: Health Care

Health care stocks were steady pre-bell Friday, with the iShares Biotechnology ETF (IBB) inactive and the State Street Health Care Select Sector SPDR ETF (XLV) marginally lower.Telix Pharmaceuticals (TLX) shares were up more than 5% after the company said the US Food and Drug Administration accepted its resubmitted new drug application for its investigational glioma imaging agent Pixclara.

$TLX